# Salbutamol Tolerance Onset

> **NCT01338311** · PHASE4 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 15 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** salbutamol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01338311
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338311, "Salbutamol Tolerance Onset". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01338311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*